/cloudfront-us-east-1.images.arcpublishing.com/eluniverso/3L3B2DF7PNHLZIMBEV3YAO3QFI.jpg "COVID-19: Analyzed coagulant blood clots potentially found with Johnson & Johnson’s gun | Salud | La Revista")
He reported four grave cases of unusual blood clots with a low level of plaques.
The European Union’s drug regulator said the woman had initiated an examination of possible lesions between the vaccine against the Johnson & Johnson coronavirus and sanguine coagulas through the information in four cases, one of them mortal.
The European Medicines Agency (EMA) says that its safety committee “initiated the revision of a safety signal to evaluate the information on thromboembolic events” with persons receiving the vaccine.
“Several serious cases of strange blood clots were reported with a level of plaques following the evacuation of the Janssen vaccine against covid-19”, the EMA said, referring to the European branch of the pharmaceutical giant Estadounidense.
“A case is being produced in a clinical setting and three cases are being produced during the deployment of the vaccine in the United States. One of those deadly forces ”, added.
The EMA approves the use of the Johnson & Johnson vaccine, but in its 27 countries’ 27 countries no final results will be announced this month. (I)